Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the populationIRVINE, Calif., June 24,...
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that as...
Salted Caramel Pretzel Bites by Bogart's Kitchen TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX:...
ROCKAWAY, NJ, June 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication...
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized...
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a...
Co-founder and Chief Scientific Officer of Optinose AS honored for his invention of the technology used in the Optinose Exhalation...
Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none of which are disease-modifyingDosing of...
Anticipates FDA PDUFA goal date in late 2021If approved by the FDA for US market access, Libervant would be the...
WATERTOWN, Mass., June 24, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™...
Provides Compelling Rationale for the Upcoming Phase 2b Clinical Study in Patients with Poor Response to Androgen Receptor Signaling InhibitorsCALGARY,...
SOUTH SAN FRANCISCO, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal...
WILMETTE, Ill., June 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
The Company’s Reach has Grown to Over 317 Million in Just 14 Months and Monetization is Now UnderwayLOS ANGELES, CA,...
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile...
VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an...
BOULDER, Colo., June 24, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical...
Abstract presentation highlights safety and potential efficacy of Lomecel-B infusion in patients with mild Alzheimer’s DiseaseMIAMI, June 24, 2021 (GLOBE...
SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing...
Retailer Extends Relationship with Inovalon to 2028BOWIE, Md., June 24, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider...